Did You Know?

Editor’s Picks

Latest News

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism

Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...

Ultrasound-on-Chip Licensing Market to Reach USD 200.5 Million by 2036 as AI-Enabled Imaging and Embedded Ultrasound Technologies Drive Healthcare Innovation

NEWARK, Del., July 13, 2026 /PRNewswire/ -- According to Future Market Insights (FMI), the global Ultrasound-on-Chip Licensing Market is projected to grow...

Rejuvenate Muscle Health(TM) Expands its Position in the Emerging GLP-1 Muscle Health Category with U.S. Pharmacy Program and National E-Commerce Expansion

Top-tier U.S. grocery and pharmacy chain launches 662-store GLP-1 pharmacy merchandisingOne of North America's largest omnichannel retailers approves onboarding of...

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases

Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318...

error: Content is protected !!